Adam C. Vandervoort - 30 May 2025 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
CHIEF LEGAL OFFICER, SECRETARY
Signature
/s/ Adam C. Vandervoort
Issuer symbol
TDOC
Transactions as of
30 May 2025
Transactions value $
-$39,843
Form type
4
Filing time
03 Jun 2025, 17:37:10
Previous filing
21 Mar 2025
Next filing
03 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Vandervoort Adam C CHIEF LEGAL OFFICER, SECRETARY C/O TELADOC HEALTH, INC.,, 155 E 44TH ST, FLOOR 17, NEW YORK /s/ Adam C. Vandervoort 2025-06-03 0001375088

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +1.51K +2.34% 65.8K 30 May 2025 Direct F1
transaction TDOC Common Stock Options Exercise +4.42K +6.71% 70.2K 30 May 2025 Direct F2
transaction TDOC Common Stock Options Exercise +5.35K +7.62% 75.6K 30 May 2025 Direct F2
transaction TDOC Common Stock Sale -$39.8K -5.81K -7.68% $6.86 69.8K 02 Jun 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Performance Stock Units Options Exercise $0 -1.51K -24.98% $0.00 4.52K 30 May 2025 Common Stock 1.51K Direct F1, F4
transaction TDOC Restricted Stock Units Options Exercise $0 -4.42K -25% $0.00 13.3K 30 May 2025 Common Stock 4.42K Direct F2, F5
transaction TDOC Restricted Stock Units Options Exercise $0 -5.35K -12.5% $0.00 37.5K 30 May 2025 Common Stock 5.35K Direct F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F3 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4 The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F5 On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6 One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.